Condition
    Strong Evidence
    Effectiveness 3/5

    Glycine for Insomnia

    Glycine 3 g before bed improves subjective sleep quality and next-day alertness in people with mild sleep complaints, with a clean safety profile.

    Overview

    Glycine at 3 g before bed is one of the gentler sleep interventions with human polysomnographic data behind it. In crossover studies of people with mild sleep complaints, it shortened the time taken to reach slow-wave sleep, improved subjective sleep quality and — notably — reduced next-day fatigue rather than causing grogginess. The trials are small. The best-known one enrolled 11 volunteers, so the physiology is better established than the effect size.
    Practically, glycine suits people who fall asleep slowly or wake unrefreshed, rather than those with chronic insomnia disorder, where cognitive behavioural therapy for insomnia remains first-line and considerably more effective.

    Verdict

    Likely effective

    Small crossover trials with objective polysomnography show faster onset of slow-wave sleep and better subjective quality at 3 g before bed, with low adverse effects. Sample sizes are very small and chronic insomnia populations are under-studied.

    How It Works

    Glycine is an inhibitory neurotransmitter in its own right, acting at strychnine-sensitive glycine receptors in the brainstem and spinal cord, and also as an obligatory co-agonist at the NMDA receptor glycine site. This dual role lets it shift the balance of excitation and inhibition without the receptor profile of a sedative-hypnotic.
    The best-supported route to better sleep is thermoregulatory. Glycine acts on NMDA receptors in the suprachiasmatic nucleus to promote peripheral vasodilation, increasing heat loss through the hands and feet and lowering core body temperature. A falling core temperature is one of the physiological triggers for sleep onset, which is why the effect shows up as faster progression into slow-wave sleep rather than as sedation. Because it is not sedating, it does not produce the hangover effect associated with hypnotics — consistent with the reduced daytime fatigue reported in the trials.

    Dosing & Protocol

    Timing matters more than dose. Take 3 g roughly 30 to 60 minutes before bed, so the temperature drop coincides with when you want to fall asleep. Glycine is sweet-tasting and dissolves readily in water, which makes powder both cheaper and easier than capsules at this dose.

    Evidence

    The key linked study is a crossover trial in volunteers with sleep complaints, which paired subjective sleep-quality questionnaires with polysomnography. Glycine 3 g before bed shortened latency to slow-wave sleep and improved reported sleep quality. The value of this study lies in objective sleep staging; its limitation is a sample of 11.

    Only studies already linked to this pairing are shown.

    Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes

    Score: 5/10
    2007
    crossover
    n=11

    Yamadera W, Inagawa K, Chiba S +3 more

    Glycine ingestion before bedtime shortened the latency to sleep onset and to slow-wave sleep, with improved subjective sleep quality.

    View source

    Safety

    Glycine is a non-essential amino acid present in ordinary protein intake, and 3 g nightly is well tolerated. The reported effects are mild: occasional soft stools or nausea at higher doses, and a sweet aftertaste. There is no dependence, tolerance or withdrawal profile of the sort seen with hypnotics.

    When to seek help instead

    Persistent insomnia lasting more than three months, loud snoring with witnessed pauses in breathing, or daytime sleepiness severe enough to affect driving all warrant clinical assessment rather than a supplement. Use caution with significant kidney or liver disease, where amino acid loads should be discussed with a clinician, and note that safety in pregnancy has not been established at supplemental doses.

    Interactions & Conflicts

    There are no well-documented pharmacokinetic interactions at 3 g. The relevant cautions are pharmacodynamic — additive effects with other sedating agents — plus one specific psychiatric interaction worth knowing about.
    Interacts withSeverityMechanismAction
    major
    Avoid unless supervised by the prescribing psychiatrist
    moderate
    Do not combine without medical advice
    moderate
    Avoid near bedtime
    minor
    Introduce one at a time so you can tell what is working

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.